Adeshwar Meditex
- Market cap
- ₹ 25 Cr.
- P/E
- 28.9x
- P/B
- 0.61x
- 52-week range
- 13 – 21
- ROE
- 3%
- ROCE
- 5.2%
- Dividend yield
- 0%
- Debt / equity
- 0.16
- Sector
- Healthcare Services
- Industry
- Healthcare Research, Analytics & Technology
- Listed on
- BSE SME
About
Adeshwar Meditex Limited is an India-based manufacturer and exporter of sterile surgical wound dressings and medical disposables. The Company's product categories include sterile wound dressings, combine dressing, gauze dressing and cotton products, medical bandages and plaster, antiseptics/disinfectants and other product. Its sterile wound dressings products include Bactigauze, Petronet/Para heal, Bactigauze Plus, Nitro heal, Pividine Povitulle, Povizole, Framitulle, Fusitulle, Calginate-AG Silvinet, Hydrasoothe, Polybane, Polybane-N and antiseptic wound care. Its combine dressing products include Eye Pad and Combidress/Combipad (with or without X-ray thread). Its gauze dressing and cotton products include Cotton Stockinette, Cast Padding - Orthowrap, Rolled Cotton Bandages, Absorbent Cotton Wool, Abdominal Pad, Gauze Swab and Triangular Bandages. Its medical bandages and plaster include Elastic Adhesive Bandage, Cohesive Bandage, Adhesive Tape, Microporous tape and others.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Healthcare Research, Analytics & Technology: 11 companies →Adeshwar Meditex against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)28.9 against a typical 34.7: cheaper than most peers (1st = cheapest).5th of 11
- Sales growth−22.4% against a typical +16.4% from a year earlier.9th of 10
- Profit growth−58.6% against a typical 0% from a year earlier.4th of 5
- Share price, 3 months−6.7% against a typical −11.4%.5th of 11
- Size₹ 24.9 Cr. market value against a typical ₹ 197.8 Cr. (1st = largest).10th of 11
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 37 | 29 | 30 | 35 | 46 | 36 | 46 | 34 | 41 | 37 | 30 | 26 |
| Expenses | 35 | 26 | 28 | 33 | 43 | 34 | 44 | 31 | 39 | 35 | 29 | 25 |
| Operating Profit | 2 | 3 | 2 | 1 | 3 | 2 | 2 | 3 | 2 | 2 | 2 | 1 |
| OPM % | 4.5% | 10.1% | 6.9% | 3.7% | 5.9% | 6.8% | 4.8% | 8.9% | 4.9% | 5.8% | 5.1% | 4.7% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 2 | 1 | 0 | 2 | 1 | 1 | 2 | 1 | 2 | 1 | 1 |
| Tax % | 29.8% | 27.3% | 26.1% | 59.3% | 27.8% | 29.3% | 25.8% | 29.1% | 28% | 27.3% | 28.4% | 34.6% |
| Net Profit | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS in Rs | 0.63 | 1.29 | 0.47 | 0.08 | 0.76 | 0.69 | 0.51 | 0.89 | 0.62 | 0.93 | 0.51 | 0.37 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- −3%
- 3 Years
- −12%
- TTM
- −33%
- 10 Years
- —
- 5 Years
- −7%
- 3 Years
- −15%
- TTM
- −36%
- 10 Years
- —
- 5 Years
- −11%
- 3 Years
- −9%
- TTM
- —
- 10 Years
- —
- 5 Years
- 5%
- 3 Years
- 5%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Adeshwar Meditex | ₹ 15.80 | ₹ 25 Cr. | 28.9x | 0.6x | 3% | — |
| Lenskart Solutions | ₹ 626.45 | ₹ 1,08,768 Cr. | 215.1x | 12.7x | — | 6.9% |
| Poly Medicure | ₹ 1,444.00 | ₹ 14,553 Cr. | 48.3x | 5.1x | — | 15.7% |
| Laxmi Dental | ₹ 170.22 | ₹ 937 Cr. | 27x | 3.8x | — | 10% |
| Hemant Surgical Industries | ₹ 665.00 | ₹ 967 Cr. | 41.1x | 5.6x | 18.1% | 7.9% |
| Mallcom (India) | ₹ 893.80 | ₹ 558 Cr. | 18.8x | 1.9x | — | 5.1% |
Prices are delayed and for information only. Nothing on this page is investment advice.